직접 대면 방식과 병행한 전화를 이용한 복약상담이 제 2형 당뇨병 환자의 치료성과에 미치는 영향 = The Effects of Follow-up Telephone Calls Combined with Face-to-face Meetings on Clinical and Humanistic Outcomes in Patients with Type 2 Diabetes Mellitus

다국어 초록 (Multilingual Abstract)

There is a lack of evidence on the impact of pharmacist interventions in diabetes care in South Korea. The aim
of this study was to investigate the effects of pharmacist counseling on clinical and humanistic outcomes in patients with type 2 diabetes. An uncontrolled before-and-after study was conducted at the outpatient diabetes clinic in a teaching hospital in Gyeongnam, South Korea between January 2 and November 30, 2014. A total of 37 patients were enrolled. During the study periods, the participants and pharmacists met every 2 weeks via follow-up telephone calls in addition to face-to-face meetings upon returning for care visit. At each meeting, a structured patient counseling was performed and the average duration of each meeting was 15~30 minutes. The participants were requested to record daily self-care activities. At the end of this study, patients’ satisfaction on pharmacist care was evaluated using the questionnaire developed by us. Compared to baseline, significant reductions (mean±standard deviation, p<0.05) in HbA1c were observed at each follow-up period:
−0.32±0.72% from baseline to 3 months; −0.52±0.76% from baseline to 6 months; −0.72±0.76% from baseline to 9 months.
Over the same follow-up period, the proportions of patients achieving target HbA1c (defined as HbA1c<6.5%) were 3.1%, 10.3%, and 20%, respectively. The proportions of patients who never missed a dose during the same follow-up period were 43.8%, 31.0%, and 20.0%, respectively. The results from the patient satisfaction survey indicated that pharmacist counseling improved patients’ knowledge about diabetes and possible drug interactions. Especially, the information on a healthy diet and lifestyle was the most satisfying. To conclude, follow-up telephone calls combined with face-to-face meetings improved clinical and humanistic outcomes in patients with type 2 diabetes mellitus.

참고문헌 (Reference)

1 "건강보험심사평가원, 국민건강보험공단. 2013년 건강보험통계연보. Available from" 건강보험통계연보

2 "World Health Organization: Diabetes. Available from"

3 American Diabetes Association, "Standards of medical care in diabetes--2013" 36 (36): S11-, 2013

4 Machado, M, "Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management" 41 : 1569-, 2007

5 Johnson, C. L, "Outcomes from DiabetesCARE: a pharmacist-provided diabetes management service" 48 : 722-, 2003

6 Fowler, M. J, "Microvascular and macrovascular complications of diabetes" 26 : 77-, 2008

7 Brown, M. T, "Medication adherence: WHO cares?" 86 : 304-, 2011

8 "Korean diabetes association. 당뇨병교실. 치료 및 관리. Available from URL"

9 "Korean Diabetes Association/Korea Centers for Disease Control and Prevention: Diabetes fact sheet in Korea"

10 KOSIS, "KOSIS. 사망원인통계. Available from"

11 "International Diabetes Federation. IDF Diabetes atlas, 6th ed. Key findings 2014. Available from"

12 Al Mazroui, N. R, "Influence of pharmaceutical care on health outcomes in patients with type 2 diabetes mellitus" 67 : 547-, 2009

13 Ruba A. Wishah, "Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: Randomized controlled trial" Elsevier BV 9 (9): 271-276, 2015

14 Chatterjee, J. S, "From compliance to concordance in diabetes" 32 : 507-, 2006

15 Kooy, M. J, "Effects of a TELephone Counselling Intervention by Pharmacist (TelCIP) on medication adherence, patient beliefs and satisfaction with information for patients starting treatment: study protocol for a cluster randomized controlled trial" 14 : 219-, 2014

16 Mehuys, E, "Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial" 36 : 602-, 2011

17 American Diabetes Association, "Diagnosis and Classification of Diabetes Mellitus" 31 : S62-, 2008

18 "Diabetes UK. 10 things to think about on World Diabetes Day. Available from"

19 Fera, T, "Diabetes Ten City Challenge: final economic and clinical results" 49 : 383-, 2003

20 Stratton, I. M, "Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study" 321 : 405-, 2000

21 Iyer, R, "An employer-based, pharmacist intervention model for patients with type 2 diabetes" 67 : 312-, 2010